The largest database of trusted experimental protocols

Sigmaplot v11

Manufactured by Merck Group
Sourced in United States

SigmaPlot v11.0 is a data analysis and graphing software developed by Systat Software, Inc. It is designed to help users create high-quality scientific and technical graphs and perform advanced data analysis. The software offers a range of features for data manipulation, curve fitting, and statistical analysis.

Automatically generated - may contain errors

68 protocols using sigmaplot v11

1

Antioxidant Effects on Parkinson's Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data are presented as mean values (M) and standard deviations (SD). For the statistical assessment of the results from the Apomorphine test, the nonparametric Kruskal–Wallis one-way analysis of variance (ANOVA) with Tukey posthoc tests were applied, as appropriate. For the results from TBARS and GPx evaluation, a two-way ANOVA was conducted on the influence of the two independent variables (treatment group, brain hemisphere). The treatment group included G1, G2, G3, and G4, as per Figure 1, and the brain hemisphere consisted of left and right hemispheres, which were evaluated separately. To isolate which groups differed from the other, a multiple comparison procedure was used. The level of significance p < 0.05 was accepted. SigmaPlot, v. 11.0 was used for statistical evaluation. All rats survived the 6-OHDA unilateral intrastriatal injection and were included in the statistical analysis.
+ Open protocol
+ Expand
2

Log-Transformed ANOVA with LSD Post Hoc

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis of data was performed utilizing SigmaPlot (v. 11.0). The test of significance was performed using either one-way ANOVA (Saline x LPS) or two-way ANOVA (pretreatment [Water or CORT] x exposure [Saline or LPS/PIC]) on log transformed values followed by multiple pairwise comparison analysis using Fisher least significant difference (LSD) post hoc test with statistical significance at 5% (p<0.05). Graphical representations are mean ± SEM.
+ Open protocol
+ Expand
3

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
The assumption of normality was tested with the Shapiro-Wilk test for normality prior to additional analysis (Sigma Plot v11.0). Normally distributed data were analyzed by Student's unpaired, two-tailed t-test (2 groups) or ANOVA (>2 groups). Data not normally distributed were analyzed using the Mann-Whitney U test (2 groups) or Kruskal-Wallis one-way ANOVA (>2 groups). P-values less than 0.05 were considered significant for all comparisons.
+ Open protocol
+ Expand
4

Evaluating Cellular Responses to Stimuli

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data are means ± SE. Statistical analyses were performed, and graphs were constructed using SigmaPlot v11.0. Unpaired or paired t tests were used to compare two groups. Multiple groups were compared using one-way or two-way analysis of variance followed by a Student-Newman-Keuls post hoc test to ascertain statistical differences. A value of P ≤ 0.05 was considered statistically significant for all experiments. Histograms were constructed and fit to multiple Gaussian functions using OriginPro v8.5, and SigmaPlot was used to create the figures. Concentration-response curves were made by fitting data to a four-parameter logistic equation using SigmaPlot.
+ Open protocol
+ Expand
5

Skin Delivery Data Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Skin delivery data were expressed as mean ± SD. Outliers were determined using the Dixon’s Q test (α = 0.05) and discarded. Results were evaluated statistically using SigmaPlot v.11.0. Groups were compared using either analysis of variance (ANOVA) or analysis of means by Student’s t-test. Student Newman Keuls test or Bonferroni T-test were used when necessary as post-hoc procedures. The level of significance was fixed at α = 0.05. (the detailed statistics are presented in Supplementary Information Section 3).
+ Open protocol
+ Expand
6

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
We conducted one‐way ANOVA, two‐tailed t‐test, linear and nonlinear regression analysis test using Sigma Plot v11.0. Normal distribution and equal variance were assessed using Statistical software from Sigma Plot vs11.0. Wilcoxon–Mann–Whitney tests were conducted using IBM SPSS Statistics 19.
+ Open protocol
+ Expand
7

Comprehensive Analysis of Cytokine Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
SigmaPlot v11.0 was used for data analysis. Age was analyzed using analysis of variance (ANOVA), and the other items were analyzed using the chi-square test or Fisher’s exact probability test. The chi-square test was used to test categorical variables. To identify a significant difference in alpha diversity, the Kruskal–Wallis rank-sum test was used to evaluate the differences in diversity among the three groups, followed by Dunn’s test of multiple comparisons. To analyze genus differences, the Mann–Whitney test and Wilcoxon signed-rank test were used for the comparative analysis within and between the vaginal and cervical microbiota, respectively. All samples were clustered to low, medium, and high levels to determine the correlation coefficients between individual cytokines according to cytokine levels (logarithm of 10) by average linkage cluster. p < 0.05 was considered statistically significant.
+ Open protocol
+ Expand
8

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data are expressed as means±S.E.M. and analyzed using GraphPad Prism® v5.0 (La Jolla, CA) and SigmaPlot® v11.0 (San Jose, CA) software. Unpaired and paired Student’s t-tests as well as ANOVA followed by Bonferroni post test was performed, as appropriate, to analyze for statistical differences between groups with P<0.05 considered statistically significant.
+ Open protocol
+ Expand
9

Dietary Effects on Multiparous Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were tested for normality and equal variance, and expressed as mean ± S.D., unless otherwise specified. Two-way ANOVA was conducted using factors [Diet (control vs. LPD) × gender (male vs. female)] followed by Student-Newman-Keuls post-hoc test. For non-parametric data, two-way ANOVA on ranks was performed. All statistical tests were conducted at P<0.05 (SigmaPlot v11.0, San Jose, CA).
All experiments include a sample size of 5–6 litters in each diet group, except for in vitro protein binding study where serum from all litters in a diet group were pooled to perform the experiment. Whenever data from two or more littermates were available, an average value was calculated, and considered as a single data point. The arithmetic mean ± S.D. of the litters (5–6) was reported. This is the recommended method of calculating a mean for multiparous species to avoid artificial inflation of the power of statistical tests (Holson and Pearce, 1992 (link); Zorrilla, 1997 (link)).
+ Open protocol
+ Expand
10

Quantitative Analysis of Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data are expressed as mean value ± standard error of mean (mean ± SEM). If not stated otherwise, levels of significance between groups were calculated using student’s t-test after proving normal distribution. Multiple comparisons were made by factorial variance analysis (ANOVA) adjusted according to Bonferroni (statistical software: Sigma Plot v. 11.0). Levels of statistical significance are indicated as follows *- p<0.05, **- p< 0.01 and ***- p<0.001. All experiments were carried out at least three times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!